James Christensen

Directeur/Membre du Conseil chez BOUNDLESS BIO, INC.

Fortune : - $ au 31/05/2024

55 ans

Health Technology

Consumer Services

Finance

Postes actifs de James Christensen

Sociétés	Poste	Début	Fin
BOUNDLESS BIO, INC.	Directeur/Membre du Conseil	02/10/2023	-
BOUNDLESS BIO, INC.	Independent Dir/Board Member	02/10/2023	-

Sociétés	Poste	Début	Fin
MIRATI THERAPEUTICS	Directeur Technique/Scientifique/R&D	01/06/2013	23/01/2024
PFIZER, INC.	Corporate Officer/Principal	01/01/2003	01/01/2013
TANGO THERAPEUTICS, INC.	Directeur/Membre du Conseil	30/07/2020	-
TANGO THERAPEUTICS, INC.	Independent Dir/Board Member	30/07/2020	-

North Carolina State University	Doctorate Degree
Northern Illinois University	Undergraduate Degree

Internationale

Etats-Unis

Opérationnelle

Director/Board Member	2
Independent Dir/Board Member	2
Chief Tech/Sci/R&D Officer	1

Sectorielle

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	2
PFIZER, INC.	Health Technology
BOUNDLESS BIO, INC.	Health Technology

Entreprise privées	2
Mirati Therapeutics, Inc. Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA.	Health Technology
BCTG Acquisition Corp. BCTG Acquisition Corp. Financial ConglomeratesFinance BCTG Acquisition Corp. operates as a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded in May 2020 and is headquartered in San Diego, CA.	Finance

Entreprise privées

Health Technology

Finance